1Latge JP , Kobayashi H , Debeaupuis JP , et al. Chemical and immunological charcterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun, 1994, 62(12) : 5424- 5433.
2Bretagne S, Marmorat-Khuong A, Kuentz M, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA : practical use in neutropenic patients. J Infect, 1997, 35 (1) : 7-15.
3Verweij PE, Rijs AJ, De Pauw BE, et al. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol, 1995, 48(5) : 474-476.
4Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis, 1996, 15 (2) : 139-145.
5Hurst SF, Reyes GH, McLaughlin DW, et al. Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbitmodel of invasive Aspergillosis. Clin Diag Lab Immu, 2000,7 (3) :477-485.
6Maertens J, Verhaegen J, Demuynck H, et al. Autopsycontrolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis.J Clin Microbiol, 1999, 37 (10) : 3223-3228.
7Chamilos G, Kontoyiannis DP. Defining the diagnosis of invasive aspergillosis. Med Mycol,2006, 44 ( SI ) : 163-172.
8Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patents at high risk for invasive fungal infect ion: a prospective feasibility study. Clin Infect Dis, 2005, 41 (9) : 1242-1250.
9Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: inereasing antigenemia is associated with progressive disease. Clin Infect Dis, 2002, 34(7) : 939-943.
10Pazos C, dei Palacio A. Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus. Rev Iberoam Micol, 2003, 20(3): 99-102.
7BONDUEL M,SANTOS P,TURIENZO CF, et al. Atypical skin lesions caused by Curvularia sp and Pseudallescheria boydii in two patients after allogeneic bone marrow trans- plantation[J]. Bone M arrow Transplant, 2001,27 (12) : 1311-1313.
8YEAR H, SENDID B, FRANCOIS N, et al. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis[J]. Eur J Clin Microbiol Infect Dis, 2001,20(12) : 864-870.
9OSTROSKY-ZEICHNERL, ALEXANDERBD, KETTDH, et al. 1Multicenter clinical evaluation of the (1 3) beta-D- glucan assay as an aid todiagnosis of fungal infections in hu- mans[J]. Clin InfectDis, 2005,41 (5) : 654-659.
10BOUTBOULF, ALBERTIC, LEBLANC T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive dis ease[J]. Clin InfectDis,2002, 34(7) :939-943.
